Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
CinCor Pharma announces late-breaking presentation of Phase 2 BrigHtn Data » 08:12
09/28/22
09/28
08:12
09/28/22
08:12
CINC

CinCor Pharma

$29.01 /

+0.39 (+1.36%)

CinCor Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CINC CinCor Pharma
$29.01 /

+0.39 (+1.36%)

CINC CinCor Pharma
$29.01 /

+0.39 (+1.36%)

09/26/22
CinCor Pharma initiated with an Outperform at LifeSci Capital
08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
CINC CinCor Pharma
$29.01 /

+0.39 (+1.36%)

  • 11
    Aug
  • 07
    Jan
CINC CinCor Pharma
$29.01 /

+0.39 (+1.36%)

CINC CinCor Pharma
$29.01 /

+0.39 (+1.36%)

Monday
Initiation
CinCor Pharma initiated with an Outperform at LifeSci Capital » 07:10
09/26/22
09/26
07:10
09/26/22
07:10
CINC

CinCor Pharma

$27.88 /

-0.17 (-0.61%)

LifeSci Capital initiated…

LifeSci Capital initiated coverage of CinCor Pharma with an Outperform rating and $64 price target.

ShowHide Related Items >><<
CINC CinCor Pharma
$27.88 /

-0.17 (-0.61%)

CINC CinCor Pharma
$27.88 /

-0.17 (-0.61%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
CINC CinCor Pharma
$27.88 /

-0.17 (-0.61%)

  • 11
    Aug
  • 07
    Jan
CINC CinCor Pharma
$27.88 /

-0.17 (-0.61%)

CINC CinCor Pharma
$27.88 /

-0.17 (-0.61%)

Over a week ago
Conference/Events
Citigroup to hold a conference » 04:55
09/08/22
09/08
04:55
09/08/22
04:55
ALDX

Aldeyra

$6.44 /

+0.15 (+2.38%)

, AMGN

Amgen

$244.84 /

+2.59 (+1.07%)

, ATAI

Atai Life Sciences

$4.28 /

+0.06 (+1.42%)

, CINC

CinCor Pharma

$29.61 /

-0.225 (-0.75%)

, CLLS

Cellectis

$3.25 /

+0.13 (+4.17%)

, DBTX

Decibel Therapeutics

$5.08 /

+0.42 (+9.01%)

, DNLI

Denali Therapeutics

$29.48 /

+2.34 (+8.62%)

, PLRX

Pliant Therapeutics

$20.11 /

+0.31 (+1.57%)

, PFE

Pfizer

$46.14 /

+0.34 (+0.74%)

, PEAR

Pear Therapeutics

$1.92 /

-0.15 (-7.25%)

, NVS

Novartis

$80.93 /

+1.16 (+1.45%)

, NCNA

NuCana

$1.41 /

+0.05 (+3.68%)

, LLY

Eli Lilly

$311.68 /

+4.94 (+1.61%)

, ROIV

Roivant Sciences

$3.48 /

+0.18 (+5.46%)

, SDGR

Schrodinger

$27.08 /

+1.12 (+4.31%)

, SSTK

Shutterstock

$56.54 /

+1.575 (+2.87%)

, TSVT

2seventy Bio

$14.70 /

+0.78 (+5.60%)

, UBX

Unity Biotechnology

/

+

, ZYME

Zymeworks

$4.73 /

-0.03 (-0.63%)

, RAPT

Rapt Therapeutics

$25.36 /

+2.34 (+10.17%)

, EOLS

Evolus

$10.20 /

+1.2 (+13.33%)

17th Annual BioPharma…

17th Annual BioPharma Conference to be held in Boston on September 7-8.

ShowHide Related Items >><<
ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

SDGR Schrodinger
$27.08 /

+1.12 (+4.31%)

ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

RAPT Rapt Therapeutics
$25.36 /

+2.34 (+10.17%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

NCNA NuCana
$1.41 /

+0.05 (+3.68%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

EOLS Evolus
$10.20 /

+1.2 (+13.33%)

DNLI Denali Therapeutics
$29.48 /

+2.34 (+8.62%)

DBTX Decibel Therapeutics
$5.08 /

+0.42 (+9.01%)

CLLS Cellectis
$3.25 /

+0.13 (+4.17%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

06/09/22 Citi
Aldeyra price target raised to $26 from $21 at Citi
06/08/22 Alliance Global Partners
Alliance Global says Aldeyra trading may be due to regulatory uncertainty
04/27/22 H.C. Wainwright
Aldeyra assumed with a Buy at H.C. Wainwright
04/04/22 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
AMGN Amgen
$244.84 /

+2.59 (+1.07%)

08/08/22 Piper Sandler
Amgen combo data for Lumakras disappoints, says Piper Sandler
08/08/22 JMP Securities
Mirati Therapeutics price target raised to $110 from $90 at JMP Securities
08/05/22 RBC Capital
Amgen price target raised to $236 from $224 at RBC Capital
08/05/22 Piper Sandler
Amgen price target raised to $265 from $260 at Piper Sandler
ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
CLLS Cellectis
$3.25 /

+0.13 (+4.17%)

08/18/22 Citi
Cellectis price target raised to $36 from $34 at Citi
05/18/22 Baird
Cellectis upgraded to Outperform at Baird on valuation 'backstop'
05/18/22 Baird
Cellectis upgraded to Outperform from Neutral at Baird
05/13/22 Barclays
Cellectis price target lowered to $7 from $9 at Barclays
DBTX Decibel Therapeutics
$5.08 /

+0.42 (+9.01%)

05/17/22 Citi
Decibel Therapeutics price target lowered to $15 from $20 at Citi
04/19/22 Baird
Decibel could be next target for Regeneron, says Baird
03/21/22 Barclays
Decibel Therapeutics price target lowered to $7 from $30 at Barclays
12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
DNLI Denali Therapeutics
$29.48 /

+2.34 (+8.62%)

06/23/22 Berenberg
Denali Therapeutics initiated with a Buy at Berenberg
05/06/22 Wedbush
Denali Therapeutics price target lowered to $48 from $62 at Wedbush
12/09/21 Raymond James
Denali Therapeutics assumed with a Market Perform at Raymond James
11/05/21 Evercore ISI
Denali Therapeutics price target raised to $111 from $70 at Evercore ISI
PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

09/01/22 Citi
Pliant Therapeutics initiated with a Buy at Citi
08/09/22 H.C. Wainwright
Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright
07/26/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald
07/20/22 SVB Securities
Pliant Therapeutics initiated with an Outperform at SVB Securities
PFE Pfizer
$46.14 /

+0.34 (+0.74%)

09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
08/18/22 Piper Sandler
Biohaven downgraded to Neutral from Overweight at Piper Sandler
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

08/12/22 BTIG
Pear Therapeutics price target lowered to $5 from $11 at BTIG
08/12/22 Chardan
Pear Therapeutics price target lowered to $9 from $13 at Chardan
06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
NVS Novartis
$80.93 /

+1.16 (+1.45%)

09/07/22 Morgan Stanley
Novartis price target lowered to CHF 88 from CHF 97 at Morgan Stanley
09/07/22 Kepler Cheuvreux
Novartis upgraded to Buy from Hold at Kepler Cheuvreux
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
NCNA NuCana
$1.41 /

+0.05 (+3.68%)

04/13/22 Truist
NuCana price target lowered to $6 from $22 at Truist
03/03/22 Cowen
NuCana downgraded to Market Perform at Cowen after trial failure
03/03/22 Cowen
NuCana downgraded to Market Perform from Outperform at Cowen
11/24/21 H.C. Wainwright
NuCana price target lowered to $9 from $10 at H.C. Wainwright
LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

09/06/22 Morgan Stanley
Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
09/06/22 BMO Capital
Eli Lilly price target raised to $396 from $369 at BMO Capital
08/30/22 Piper Sandler
Altimmune management confident on NAFLD Phase 1b study, says Piper Sandler
08/25/22 Citi
Eli Lilly price target raised to $370 from $285 at Citi
ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
SDGR Schrodinger
$27.08 /

+1.12 (+4.31%)

07/26/22 Piper Sandler
Schrodinger price target raised to $86 from $84 at Piper Sandler
06/28/22 Piper Sandler
Piper says Schrodinger has 'potentially best-in-class' MALT1 inhibitor in '1505
04/12/22 Piper Sandler
Schrodinger has 'potent and highly selective' molecule , says Piper Sandler
02/28/22 Citi
Schrodinger initiated with a Buy at Citi
SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

08/25/22 Redburn
Redburn starts Shutterstock with Buy, Getty Images with Neutral
08/25/22 Redburn
Shutterstock initiated with a Buy at Redburn
07/28/22 Morgan Stanley
Shutterstock initiated with an Equal Weight at Morgan Stanley
07/27/22 Truist
Shutterstock price target lowered to $100 from $120 at Truist
TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

08/12/22 Canaccord
2seventy Bio price target lowered to $28 from $42 at Canaccord
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
05/02/22 Goldman Sachs
2seventy Bio initiated with a Buy at Goldman Sachs
02/10/22 SVB Securities
SVB Leerink bullish on 2seventy Bio, initiates with an Outperform
UBX Unity Biotechnology
/

+

08/19/22 Wedbush
Unity Biotechnology selloff a buying opportunity, says Wedbush
08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

08/29/22 Citi
Zymeworks price target lowered to $27 from $28 at Citi
05/23/22 H.C. Wainwright
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright
05/09/22 Citi
Zymeworks should reject 'opportunistic' $10.50 per share offer, says Citi
05/05/22 Guggenheim
Zymeworks upgraded to Buy at Guggenheim amid low expectations
RAPT Rapt Therapeutics
$25.36 /

+2.34 (+10.17%)

05/24/22 Cantor Fitzgerald
Rapt Therapeutics assumed with an Overweight at Cantor Fitzgerald
05/12/22 Piper Sandler
Rapt Therapeutics price target lowered to $30 from $52 at Piper Sandler
12/09/21 JPMorgan
Rapt Therapeutics initiated with an Overweight at JPMorgan
11/16/21 Cantor Fitzgerald
Rapt Therapeutics price target lowered to $58 from $71 at Cantor Fitzgerald
EOLS Evolus
$10.20 /

+1.2 (+13.33%)

06/23/22 Needham
Needham starts 'aesthetics emerging star' Evolus at Buy
06/23/22 Needham
Evolus initiated with a Buy at Needham
05/12/22 Barclays
Evolus upgraded to Equal Weight from Underweight at Barclays
04/28/22 Barclays
Evolus price target raised to $8 from $7 at Barclays
ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

SDGR Schrodinger
$27.08 /

+1.12 (+4.31%)

ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

RAPT Rapt Therapeutics
$25.36 /

+2.34 (+10.17%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

NCNA NuCana
$1.41 /

+0.05 (+3.68%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

EOLS Evolus
$10.20 /

+1.2 (+13.33%)

DNLI Denali Therapeutics
$29.48 /

+2.34 (+8.62%)

CLLS Cellectis
$3.25 /

+0.13 (+4.17%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

  • 18
    Aug
  • 11
    Aug
  • 13
    Jul
  • 27
    Jan
  • 07
    Jan
PFE Pfizer
$46.14 /

+0.34 (+0.74%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ZYME Zymeworks
$4.73 /

-0.03 (-0.63%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

SSTK Shutterstock
$56.54 /

+1.575 (+2.87%)

ROIV Roivant Sciences
$3.48 /

+0.18 (+5.46%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

DBTX Decibel Therapeutics
$5.08 /

+0.42 (+9.01%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

ATAI Atai Life Sciences
$4.28 /

+0.06 (+1.42%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

ALDX Aldeyra
$6.44 /

+0.15 (+2.38%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.70 /

+0.78 (+5.60%)

PLRX Pliant Therapeutics
$20.11 /

+0.31 (+1.57%)

PFE Pfizer
$46.14 /

+0.34 (+0.74%)

PEAR Pear Therapeutics
$1.92 /

-0.15 (-7.25%)

NVS Novartis
$80.93 /

+1.16 (+1.45%)

LLY Eli Lilly
$311.68 /

+4.94 (+1.61%)

CINC CinCor Pharma
$29.61 /

-0.225 (-0.75%)

AMGN Amgen
$244.84 /

+2.59 (+1.07%)

Conference/Events
Citigroup to hold a conference » 16:05
09/07/22
09/07
16:05
09/07/22
16:05
ALDX

Aldeyra

$6.44 /

+0.145 (+2.31%)

, AMGN

Amgen

$244.97 /

+2.72 (+1.12%)

, ATAI

Atai Life Sciences

$4.30 /

+0.08 (+1.90%)

, CINC

CinCor Pharma

$29.46 /

-0.37 (-1.24%)

, CLLS

Cellectis

$3.24 /

+0.12 (+3.85%)

, DBTX

Decibel Therapeutics

$5.13 /

+0.47 (+10.09%)

, DNLI

Denali Therapeutics

$29.43 /

+2.29 (+8.44%)

, PLRX

Pliant Therapeutics

$20.13 /

+0.33 (+1.67%)

, PFE

Pfizer

$46.20 /

+0.4 (+0.87%)

, PEAR

Pear Therapeutics

$1.91 /

-0.16 (-7.73%)

, NVS

Novartis

$80.95 /

+1.18 (+1.48%)

, NCNA

NuCana

$1.39 /

+0.025 (+1.84%)

, LLY

Eli Lilly

$312.32 /

+5.58 (+1.82%)

, ROIV

Roivant Sciences

$3.51 /

+0.21 (+6.37%)

, SDGR

Schrodinger

$27.20 /

+1.24 (+4.78%)

, SSTK

Shutterstock

$56.46 /

+1.5 (+2.73%)

, TSVT

2seventy Bio

$14.57 /

+0.65 (+4.67%)

, UBX

Unity Biotechnology

/

+

, ZYME

Zymeworks

$4.65 /

-0.105 (-2.21%)

, RAPT

Rapt Therapeutics

$25.28 /

+2.26 (+9.82%)

, EOLS

Evolus

$10.22 /

+1.22 (+13.56%)

17th Annual BioPharma…

17th Annual BioPharma Conference to be held in Boston on September 7-8.

ShowHide Related Items >><<
ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

SDGR Schrodinger
$27.20 /

+1.24 (+4.78%)

ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

RAPT Rapt Therapeutics
$25.28 /

+2.26 (+9.82%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

NCNA NuCana
$1.39 /

+0.025 (+1.84%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

EOLS Evolus
$10.22 /

+1.22 (+13.56%)

DNLI Denali Therapeutics
$29.43 /

+2.29 (+8.44%)

DBTX Decibel Therapeutics
$5.13 /

+0.47 (+10.09%)

CLLS Cellectis
$3.24 /

+0.12 (+3.85%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

06/09/22 Citi
Aldeyra price target raised to $26 from $21 at Citi
06/08/22 Alliance Global Partners
Alliance Global says Aldeyra trading may be due to regulatory uncertainty
04/27/22 H.C. Wainwright
Aldeyra assumed with a Buy at H.C. Wainwright
04/04/22 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
AMGN Amgen
$244.97 /

+2.72 (+1.12%)

08/08/22 Piper Sandler
Amgen combo data for Lumakras disappoints, says Piper Sandler
08/08/22 JMP Securities
Mirati Therapeutics price target raised to $110 from $90 at JMP Securities
08/05/22 RBC Capital
Amgen price target raised to $236 from $224 at RBC Capital
08/05/22 Piper Sandler
Amgen price target raised to $265 from $260 at Piper Sandler
ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
CLLS Cellectis
$3.24 /

+0.12 (+3.85%)

08/18/22 Citi
Cellectis price target raised to $36 from $34 at Citi
05/18/22 Baird
Cellectis upgraded to Outperform at Baird on valuation 'backstop'
05/18/22 Baird
Cellectis upgraded to Outperform from Neutral at Baird
05/13/22 Barclays
Cellectis price target lowered to $7 from $9 at Barclays
DBTX Decibel Therapeutics
$5.13 /

+0.47 (+10.09%)

05/17/22 Citi
Decibel Therapeutics price target lowered to $15 from $20 at Citi
04/19/22 Baird
Decibel could be next target for Regeneron, says Baird
03/21/22 Barclays
Decibel Therapeutics price target lowered to $7 from $30 at Barclays
12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
DNLI Denali Therapeutics
$29.43 /

+2.29 (+8.44%)

06/23/22 Berenberg
Denali Therapeutics initiated with a Buy at Berenberg
05/06/22 Wedbush
Denali Therapeutics price target lowered to $48 from $62 at Wedbush
12/09/21 Raymond James
Denali Therapeutics assumed with a Market Perform at Raymond James
11/05/21 Evercore ISI
Denali Therapeutics price target raised to $111 from $70 at Evercore ISI
PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

09/01/22 Citi
Pliant Therapeutics initiated with a Buy at Citi
08/09/22 H.C. Wainwright
Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright
07/26/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald
07/20/22 SVB Securities
Pliant Therapeutics initiated with an Outperform at SVB Securities
PFE Pfizer
$46.20 /

+0.4 (+0.87%)

09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
08/18/22 Piper Sandler
Biohaven downgraded to Neutral from Overweight at Piper Sandler
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

08/12/22 BTIG
Pear Therapeutics price target lowered to $5 from $11 at BTIG
08/12/22 Chardan
Pear Therapeutics price target lowered to $9 from $13 at Chardan
06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
NVS Novartis
$80.95 /

+1.18 (+1.48%)

09/07/22 Morgan Stanley
Novartis price target lowered to CHF 88 from CHF 97 at Morgan Stanley
09/07/22 Kepler Cheuvreux
Novartis upgraded to Buy from Hold at Kepler Cheuvreux
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
NCNA NuCana
$1.39 /

+0.025 (+1.84%)

04/13/22 Truist
NuCana price target lowered to $6 from $22 at Truist
03/03/22 Cowen
NuCana downgraded to Market Perform at Cowen after trial failure
03/03/22 Cowen
NuCana downgraded to Market Perform from Outperform at Cowen
11/24/21 H.C. Wainwright
NuCana price target lowered to $9 from $10 at H.C. Wainwright
LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

09/06/22 Morgan Stanley
Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
09/06/22 BMO Capital
Eli Lilly price target raised to $396 from $369 at BMO Capital
08/30/22 Piper Sandler
Altimmune management confident on NAFLD Phase 1b study, says Piper Sandler
08/25/22 Citi
Eli Lilly price target raised to $370 from $285 at Citi
ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
SDGR Schrodinger
$27.20 /

+1.24 (+4.78%)

07/26/22 Piper Sandler
Schrodinger price target raised to $86 from $84 at Piper Sandler
06/28/22 Piper Sandler
Piper says Schrodinger has 'potentially best-in-class' MALT1 inhibitor in '1505
04/12/22 Piper Sandler
Schrodinger has 'potent and highly selective' molecule , says Piper Sandler
02/28/22 Citi
Schrodinger initiated with a Buy at Citi
SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

08/25/22 Redburn
Redburn starts Shutterstock with Buy, Getty Images with Neutral
08/25/22 Redburn
Shutterstock initiated with a Buy at Redburn
07/28/22 Morgan Stanley
Shutterstock initiated with an Equal Weight at Morgan Stanley
07/27/22 Truist
Shutterstock price target lowered to $100 from $120 at Truist
TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

08/12/22 Canaccord
2seventy Bio price target lowered to $28 from $42 at Canaccord
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
05/02/22 Goldman Sachs
2seventy Bio initiated with a Buy at Goldman Sachs
02/10/22 SVB Securities
SVB Leerink bullish on 2seventy Bio, initiates with an Outperform
UBX Unity Biotechnology
/

+

08/19/22 Wedbush
Unity Biotechnology selloff a buying opportunity, says Wedbush
08/15/22 Citi
Unity Biotechnology price target raised to $8 from $5 at Citi
05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

08/29/22 Citi
Zymeworks price target lowered to $27 from $28 at Citi
05/23/22 H.C. Wainwright
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright
05/09/22 Citi
Zymeworks should reject 'opportunistic' $10.50 per share offer, says Citi
05/05/22 Guggenheim
Zymeworks upgraded to Buy at Guggenheim amid low expectations
RAPT Rapt Therapeutics
$25.28 /

+2.26 (+9.82%)

05/24/22 Cantor Fitzgerald
Rapt Therapeutics assumed with an Overweight at Cantor Fitzgerald
05/12/22 Piper Sandler
Rapt Therapeutics price target lowered to $30 from $52 at Piper Sandler
12/09/21 JPMorgan
Rapt Therapeutics initiated with an Overweight at JPMorgan
11/16/21 Cantor Fitzgerald
Rapt Therapeutics price target lowered to $58 from $71 at Cantor Fitzgerald
EOLS Evolus
$10.22 /

+1.22 (+13.56%)

06/23/22 Needham
Needham starts 'aesthetics emerging star' Evolus at Buy
06/23/22 Needham
Evolus initiated with a Buy at Needham
05/12/22 Barclays
Evolus upgraded to Equal Weight from Underweight at Barclays
04/28/22 Barclays
Evolus price target raised to $8 from $7 at Barclays
ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

SDGR Schrodinger
$27.20 /

+1.24 (+4.78%)

ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

RAPT Rapt Therapeutics
$25.28 /

+2.26 (+9.82%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

NCNA NuCana
$1.39 /

+0.025 (+1.84%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

EOLS Evolus
$10.22 /

+1.22 (+13.56%)

DNLI Denali Therapeutics
$29.43 /

+2.29 (+8.44%)

CLLS Cellectis
$3.24 /

+0.12 (+3.85%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

  • 18
    Aug
  • 11
    Aug
  • 13
    Jul
  • 27
    Jan
  • 07
    Jan
PFE Pfizer
$46.20 /

+0.4 (+0.87%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ZYME Zymeworks
$4.65 /

-0.105 (-2.21%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

SSTK Shutterstock
$56.46 /

+1.5 (+2.73%)

ROIV Roivant Sciences
$3.51 /

+0.21 (+6.37%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

DBTX Decibel Therapeutics
$5.13 /

+0.47 (+10.09%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

ATAI Atai Life Sciences
$4.30 /

+0.08 (+1.90%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

ALDX Aldeyra
$6.44 /

+0.145 (+2.31%)

UBX Unity Biotechnology
/

+

TSVT 2seventy Bio
$14.57 /

+0.65 (+4.67%)

PLRX Pliant Therapeutics
$20.13 /

+0.33 (+1.67%)

PFE Pfizer
$46.20 /

+0.4 (+0.87%)

PEAR Pear Therapeutics
$1.91 /

-0.16 (-7.73%)

NVS Novartis
$80.95 /

+1.18 (+1.48%)

LLY Eli Lilly
$312.32 /

+5.58 (+1.82%)

CINC CinCor Pharma
$29.46 /

-0.37 (-1.24%)

AMGN Amgen
$244.97 /

+2.72 (+1.12%)

Over a month ago
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:56
08/22/22
08/22
09:56
08/22/22
09:56
ELV

Elevance Health

$508.26 /

+4.55 (+0.90%)

, VIPS

Vipshop

$10.51 /

+0.53 (+5.31%)

, SNDR

Schneider National

$24.69 /

-0.12 (-0.48%)

, KNX

Knight-Swift

$54.50 /

-0.99 (-1.78%)

, BRKR

Bruker

$59.78 /

+0.12 (+0.20%)

, DAO

Youdao

$5.38 /

+0.24 (+4.67%)

, NFLX

Netflix

$228.15 /

-13.26 (-5.49%)

, UPS

UPS

$205.65 /

-2.92 (-1.40%)

, COUP

Coupa Software

$65.05 /

-2.72 (-4.01%)

, DOCU

DocuSign

$63.80 /

-2.155 (-3.27%)

, SAIA

Saia

$219.34 /

-8.52 (-3.74%)

, LH

Labcorp

$248.21 /

-1.13 (-0.45%)

, DGX

Quest Diagnostics

$135.11 /

-0.39 (-0.29%)

, WALD

Waldencast Acquisition

$8.94 /

+ (+0.00%)

, PGPHF

Partners Group

$991.35 /

-48.69 (-4.68%)

, CINC

CinCor Pharma

$33.11 /

-0.21 (-0.63%)

Institutional investors…

ShowHide Related Items >><<
WALD Waldencast Acquisition
$8.94 /

+ (+0.00%)

VIPS Vipshop
$10.51 /

+0.53 (+5.31%)

UPS UPS
$205.65 /

-2.92 (-1.40%)

SNDR Schneider National
$24.69 /

-0.12 (-0.48%)

SAIA Saia
$219.34 /

-8.52 (-3.74%)

PGPHF Partners Group
$991.35 /

-48.69 (-4.68%)

NFLX Netflix
$228.15 /

-13.26 (-5.49%)

LH Labcorp
$248.21 /

-1.13 (-0.45%)

KNX Knight-Swift
$54.50 /

-0.99 (-1.78%)

ELV Elevance Health
$508.26 /

+4.55 (+0.90%)

DOCU DocuSign
$63.80 /

-2.155 (-3.27%)

DGX Quest Diagnostics
$135.11 /

-0.39 (-0.29%)

DAO Youdao
$5.38 /

+0.24 (+4.67%)

COUP Coupa Software
$65.05 /

-2.72 (-4.01%)

CINC CinCor Pharma
$33.11 /

-0.21 (-0.63%)

BRKR Bruker
$59.78 /

+0.12 (+0.20%)

ELV Elevance Health
$508.26 /

+4.55 (+0.90%)

08/22/22 SVB Securities
SVB Securities upgrades Elevance Health to Outperform, raises target to $580
08/22/22 SVB Securities
Elevance Health upgraded to Outperform from Market Perform at SVB Securities
07/28/22 Wells Fargo
Elevance Health price target lowered to $557 from $580 at Wells Fargo
07/22/22 SVB Securities
Elevance Health price target lowered to $490 from $555 at SVB Securities
VIPS Vipshop
$10.51 /

+0.53 (+5.31%)

08/22/22 Credit Suisse
Vipshop upgraded to Outperform on 'expedited' growth at Credit Suisse
08/22/22 Citi
Vipshop upgraded to Neutral from Sell at Citi
08/22/22 Credit Suisse
Vipshop upgraded to Outperform from Neutral at Credit Suisse
08/19/22 Benchmark
Vipshop Q2 results 'better than feared,' says Benchmark
SNDR Schneider National
$24.69 /

-0.12 (-0.48%)

08/22/22 Evercore ISI
Evercore upgrades Schneider to Outperform on attractive risk/reward
08/22/22 Evercore ISI
Schneider National upgraded to Outperform from In Line at Evercore ISI
07/12/22 Evercore ISI
Schneider National price target lowered to $27 from $29 at Evercore ISI
06/27/22 Credit Suisse
Schneider National initiated with an Outperform at Credit Suisse
KNX Knight-Swift
$54.50 /

-0.99 (-1.78%)

07/21/22 Susquehanna
Knight-Swift price target raised to $65 from $64 at Susquehanna
07/12/22 Stifel
Stifel sees 'strong' Q2 for Knight-Swift, trims target to $67
07/12/22 Evercore ISI
Knight-Swift upgraded to Outperform from In Line at Evercore ISI
BRKR Bruker
$59.78 /

+0.12 (+0.20%)

08/22/22 Citi
Bruker upgraded to Buy from Neutral at Citi
10/14/21 Cowen
Bruker coverage transferred at Cowen
DAO Youdao
$5.38 /

+0.24 (+4.67%)

08/22/22 CICC
Youdao upgraded to Outperform from Market Perform at CICC
07/29/22 Jefferies
Youdao price target lowered to $5.20 from $13 at Jefferies
07/29/22 Citi
Youdao price target lowered to $7.80 from $15.50 at Citi
03/07/22 Morgan Stanley
Youdao upgraded to Overweight from Equal Weight at Morgan Stanley
NFLX Netflix
$228.15 /

-13.26 (-5.49%)

08/22/22 CFRA
Netflix downgraded to Sell from Hold at CFRA
08/11/22 Wells Fargo
Disney price target raised to $145 from $130 at Wells Fargo
08/10/22 Oppenheimer
Trade Desk price target raised to $78 from $60 at Oppenheimer
08/09/22 JPMorgan
Netflix shares up 16% since earnings on narrative shift, says JPMorgan
UPS UPS
$205.65 /

-2.92 (-1.40%)

08/22/22 Evercore ISI
UPS downgraded to In Line from Outperform at Evercore ISI
07/27/22 Wells Fargo
UPS price target lowered to $223 from $270 at Wells Fargo
07/27/22 Raymond James
UPS price target lowered to $220 from $225 at Raymond James
07/27/22 Barclays
UPS price target lowered to $200 from $220 at Barclays
COUP Coupa Software
$65.05 /

-2.72 (-4.01%)

08/22/22 UBS
Coupa Software price target lowered to $76 from $84 at UBS
08/22/22 RBC Capital
Coupa Software downgraded to Underperform from Sector Perform at RBC Capital
07/18/22 Piper Sandler
Coupa Software price target lowered to $65 from $85 at Piper Sandler
07/15/22 Evercore ISI
CVS Health, Coupa added to 'Best SMID Core Ideas' list at Evercore ISI
DOCU DocuSign
$63.80 /

-2.155 (-3.27%)

08/22/22 RBC Capital
DocuSign downgraded to Sector Perform from Outperform at RBC Capital
07/21/22 Piper Sandler
DocuSign downgraded to Underweight on elevated risks at Piper Sandler
07/20/22 Piper Sandler
DocuSign downgraded to Underweight from Neutral at Piper Sandler
07/13/22 Piper Sandler
DocuSign price target lowered to $65 from $75 at Piper Sandler
SAIA Saia
$219.34 /

-8.52 (-3.74%)

08/22/22 Evercore ISI
Saia downgraded to In Line from Outperform at Evercore ISI
07/28/22 Stifel
Saia price target lowered to $229 from $238 at Stifel
07/28/22 Susquehanna
Saia price target raised to $270 from $265 at Susquehanna
07/28/22 Deutsche Bank
Saia price target lowered to $300 from $377 at Deutsche Bank
LH Labcorp
$248.21 /

-1.13 (-0.45%)

08/22/22 Morgan Stanley
Labcorp assumed with an Overweight at Morgan Stanley
07/29/22 Mizuho
LabCorp price target lowered to $296 from $323 at Mizuho
05/04/22 Mizuho
LabCorp price target lowered to $323 from $354 at Mizuho
05/03/22 Deutsche Bank
LabCorp price target lowered to $265 from $294 at Deutsche Bank
DGX Quest Diagnostics
$135.11 /

-0.39 (-0.29%)

08/22/22 Morgan Stanley
Quest Diagnostics assumed with an Equal Weight at Morgan Stanley
07/22/22 Mizuho
Quest Diagnostics price target lowered to $160 from $185 at Mizuho
07/22/22 Credit Suisse
Quest Diagnostics price target lowered to $143 from $158 at Credit Suisse
04/24/22 UBS
Quest Diagnostics price target raised to $150 from $139 at UBS
WALD Waldencast Acquisition
$8.94 /

+ (+0.00%)

08/22/22 Raymond James
Waldencast Acquisition initiated with an Outperform at Raymond James
08/17/22 Jefferies
Waldencast Acquisition initiated with a Buy at Jefferies
07/19/22 Telsey Advisory
Waldencast Acquisition initiated with an Outperform at Telsey Advisory
PGPHF Partners Group
$991.35 /

-48.69 (-4.68%)

08/22/22 Credit Suisse
Partners Group initiated with an Outperform at Credit Suisse
07/20/22 Morgan Stanley
Partners Group price target lowered to CHF 1,168 at Morgan Stanley
07/18/22 JPMorgan
Partners Group price target lowered to CHF 1,500 from CHF 1,725 at JPMorgan
07/15/22 Barclays
Partners Group price target lowered to CHF 990 from CHF 1,040 at Barclays
CINC CinCor Pharma
$33.11 /

-0.21 (-0.63%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
VIPS Vipshop
$10.51 /

+0.53 (+5.31%)

UPS UPS
$205.65 /

-2.92 (-1.40%)

SNDR Schneider National
$24.69 /

-0.12 (-0.48%)

SAIA Saia
$219.34 /

-8.52 (-3.74%)

NFLX Netflix
$228.15 /

-13.26 (-5.49%)

LH Labcorp
$248.21 /

-1.13 (-0.45%)

KNX Knight-Swift
$54.50 /

-0.99 (-1.78%)

ELV Elevance Health
$508.26 /

+4.55 (+0.90%)

DOCU DocuSign
$63.80 /

-2.155 (-3.27%)

DGX Quest Diagnostics
$135.11 /

-0.39 (-0.29%)

DAO Youdao
$5.38 /

+0.24 (+4.67%)

COUP Coupa Software
$65.05 /

-2.72 (-4.01%)

CINC CinCor Pharma
$33.11 /

-0.21 (-0.63%)

BRKR Bruker
$59.78 /

+0.12 (+0.20%)

  • 11
    Aug
  • 07
    Jan
VIPS Vipshop
$10.51 /

+0.53 (+5.31%)

UPS UPS
$205.65 /

-2.92 (-1.40%)

NFLX Netflix
$228.15 /

-13.26 (-5.49%)

LH Labcorp
$248.21 /

-1.13 (-0.45%)

ELV Elevance Health
$508.26 /

+4.55 (+0.90%)

DOCU DocuSign
$63.80 /

-2.155 (-3.27%)

VIPS Vipshop
$10.51 /

+0.53 (+5.31%)

UPS UPS
$205.65 /

-2.92 (-1.40%)

SAIA Saia
$219.34 /

-8.52 (-3.74%)

NFLX Netflix
$228.15 /

-13.26 (-5.49%)

LH Labcorp
$248.21 /

-1.13 (-0.45%)

KNX Knight-Swift
$54.50 /

-0.99 (-1.78%)

ELV Elevance Health
$508.26 /

+4.55 (+0.90%)

DOCU DocuSign
$63.80 /

-2.155 (-3.27%)

DGX Quest Diagnostics
$135.11 /

-0.39 (-0.29%)

DAO Youdao
$5.38 /

+0.24 (+4.67%)

COUP Coupa Software
$65.05 /

-2.72 (-4.01%)

CINC CinCor Pharma
$33.11 /

-0.21 (-0.63%)

UPS UPS
$205.65 /

-2.92 (-1.40%)

NFLX Netflix
$228.15 /

-13.26 (-5.49%)

KNX Knight-Swift
$54.50 /

-0.99 (-1.78%)

ELV Elevance Health
$508.26 /

+4.55 (+0.90%)

DOCU DocuSign
$63.80 /

-2.155 (-3.27%)

COUP Coupa Software
$65.05 /

-2.72 (-4.01%)

CINC CinCor Pharma
$33.11 /

-0.21 (-0.63%)

Hot Stocks
CinCor to present data on Baxdrostat from CIN-MAD study » 08:21
08/22/22
08/22
08:21
08/22/22
08:21
CINC

CinCor Pharma

$33.11 /

-1.87 (-5.35%)

CinCor Pharma announced…

CinCor Pharma announced that the company will present Phase 1 clinical data on lead candidate baxdrostat as part of a poster presentation at the upcoming European Society of Cardiology Congress taking place August 26-29, virtually and live in Barcelona, Spain. Baxdrostat is a highly selective, potent, once daily, oral inhibitor of aldosterone synthase. The presentation will include clinical data from the randomized, Phase 1, placebo controlled multiple ascending dose study which evaluated the safety, pharmacokinetics, and pharmacodynamics of baxdrostat in healthy volunteers. "Baxdrostat has an exciting new mechanism of action that we believe has encouraging potential to become the first major advancement in decades for the broad treatment of hypertension. We look forward to presenting this Phase 1 data, which will provide convincing evidence of pharmacodynamic inhibition of the drug's enzyme target, aldosterone synthase, as well as demonstrating baxdrostat's well-behaved pharmacokinetic properties and well-tolerated profile at all doses tested," said Mason Freeman, M.D., Chief Medical Officer at CinCor. "These data complement the recently announced Phase 2 BrigHtn topline data demonstrating clinically meaningful and statistically significant reduction in blood pressure as well as a compelling safety and tolerability profile following treatment with baxdrostat in patients with resistant hypertension."

ShowHide Related Items >><<
CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

08/21/22 Piper Sandler
CinCor Pharma initiated with an Overweight at Piper Sandler
08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

  • 11
    Aug
  • 07
    Jan
CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

Initiation
CinCor Pharma initiated with an Overweight at Piper Sandler » 17:21
08/21/22
08/21
17:21
08/21/22
17:21
CINC

CinCor Pharma

$33.11 /

-1.87 (-5.35%)

Piper Sandler analyst…

Piper Sandler analyst Yasmeen Rahimi initiated coverage of CinCor Pharma with an Overweight rating and $73 price target owing to the blockbuster potential in hypertension for baxdrostat, a highly selective oral CYP11B2/aldosterone synthase inhibitor. Recent Phase 2 PoC data from BrigHtn in 275 resistant HTN patients validates the mechanism in one of the most challenging forms of HTN and de-risks upcoming Phase 2 readouts across uncontrolled HTN, chronic kidney disease, and primary aldosteronism, she adds. Furthermore, a clean safety profile provides a broad therapeutic index allowing for higher dosing to enhance efficacy, Rahimi argues. Considering 116M U.S. patients with HTN and high BP accounting for 10% of global healthcare spending, the analyst believes baxdrostat is well-prepared to competitively position itself in this very attractive HTN market.

ShowHide Related Items >><<
CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
02/01/22 Evercore ISI
CinCor Pharma initiated with an Outperform at Evercore ISI
CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

  • 11
    Aug
  • 07
    Jan
CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

CINC CinCor Pharma
$33.11 /

-1.87 (-5.35%)

Syndicate
CinCor Pharma 7.5M share Secondary priced at $30.00 » 06:09
08/11/22
08/11
06:09
08/11/22
06:09
CINC

CinCor Pharma

$31.98 /

-0.89 (-2.71%)

The deal size was…

The deal size was increased to 7.5M shares of common stock from 6M shares of common stock. Goldman Sachs, Morgan Stanley, Jefferies and Piper Sandler acted as joint book running managers for the offering.

ShowHide Related Items >><<
CINC CinCor Pharma
$31.98 /

-0.89 (-2.71%)

CINC CinCor Pharma
$31.98 /

-0.89 (-2.71%)

08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
02/01/22 Evercore ISI
CinCor Pharma initiated with an Outperform at Evercore ISI
CINC CinCor Pharma
$31.98 /

-0.89 (-2.71%)

  • 11
    Aug
  • 07
    Jan
CINC CinCor Pharma
$31.98 /

-0.89 (-2.71%)

CINC CinCor Pharma
$31.98 /

-0.89 (-2.71%)

Syndicate
CinCor Pharma files to sell 6M shares of common stock, pre-funded warrants » 17:29
08/08/22
08/08
17:29
08/08/22
17:29
CINC

CinCor Pharma

$34.96 /

+11.46 (+48.77%)

Goldman Sachs & Co.,…

Goldman Sachs & Co., Morgan Stanley, Jefferies, and Piper Sandler are managing the offering.

ShowHide Related Items >><<
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
02/01/22 Evercore ISI
CinCor Pharma initiated with an Outperform at Evercore ISI
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

  • 07
    Jan
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

On The Fly
What You Missed On Wall Street On Monday » 16:46
08/08/22
08/08
16:46
08/08/22
16:46
TWTR

Twitter

$42.93 /

+0.4 (+0.94%)

, PFE

Pfizer

$49.55 /

+0.29 (+0.59%)

, GBT

Global Blood Therapeutics

$66.58 /

+2.77 (+4.34%)

, NVDA

Nvidia

$177.97 /

-11.97 (-6.30%)

, CG

Carlyle Group

$35.30 /

-2.34 (-6.22%)

, TSLA

Tesla

$870.99 /

+6.51 (+0.75%)

, EMR

Emerson Electric

$90.03 /

-0.375 (-0.41%)

, FSLR

First Solar

$106.66 /

+4.78 (+4.69%)

, TPIC

TPI Composites

$21.41 /

+2.64 (+14.06%)

, ROKU

Roku

$83.56 /

+1.32 (+1.61%)

, WBD

Warner Bros. Discovery

$14.01 /

-0.58 (-3.98%)

, WDC

Western Digital

$47.53 /

+0.42 (+0.89%)

, CVS

CVS Health

$102.00 /

-0.34 (-0.33%)

, GOOG

Alphabet

$118.17 /

-0.11 (-0.09%)

, GOOGL

Alphabet

$117.32 /

-0.17 (-0.14%)

, SONO

Sonos

$22.98 /

-0.215 (-0.93%)

, SGFY

Signify Health

$22.06 /

+2.195 (+11.05%)

, BA

Boeing

$165.90 /

+0.89 (+0.54%)

, AMZN

Amazon.com

$139.42 /

-1.37 (-0.97%)

, KRTX

Karuna Therapeutics

$241.52 /

+101.41 (+72.38%)

, CINC

CinCor Pharma

$34.96 /

+11.46 (+48.77%)

, WTI

W&T Offshore

$5.37 /

+0.775 (+16.87%)

, QURE

uniQure

$18.60 /

-6.92 (-27.12%)

, RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

, PLTR

Palantir

$9.82 /

-1.625 (-14.20%)

, TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

, BNTX

BioNTech

$169.30 /

-13.9 (-7.59%)

, ELAN

Elanco

$19.94 /

+0.47 (+2.41%)

, SRCL

Stericycle

$52.40 /

+1.85 (+3.66%)

Get caught up quickly on…

ShowHide Related Items >><<
WTI W&T Offshore
$5.37 /

+0.775 (+16.87%)

WDC Western Digital
$47.53 /

+0.42 (+0.89%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

TWTR Twitter
$42.93 /

+0.4 (+0.94%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSLA Tesla
$870.99 /

+6.51 (+0.75%)

TPIC TPI Composites
$21.41 /

+2.64 (+14.06%)

SRCL Stericycle
$52.40 /

+1.85 (+3.66%)

SONO Sonos
$22.98 /

-0.215 (-0.93%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

ROKU Roku
$83.56 /

+1.32 (+1.61%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

ELAN Elanco
$19.94 /

+0.47 (+2.41%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

BNTX BioNTech
$169.30 /

-13.9 (-7.59%)

BA Boeing
$165.90 /

+0.89 (+0.54%)

AMZN Amazon.com
$139.42 /

-1.37 (-0.97%)

TWTR Twitter
$42.93 /

+0.4 (+0.94%)

08/05/22 Susquehanna
Susquehanna downgrades Twitter on 'uncertainty and disruption' from takeover
08/05/22 Susquehanna
Twitter downgraded to Neutral from Positive at Susquehanna
07/27/22 Jefferies
Alphabet price target lowered to $130 from $155 at Jefferies
07/25/22 Cowen
Twitter price target lowered to $22 from $38 at Cowen
PFE Pfizer
$49.55 /

+0.29 (+0.59%)

08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 Oppenheimer
Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
08/08/22 Stifel
Global Blood Therapeutics downgraded to Hold from Buy at Stifel
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

08/08/22 RBC Capital
Global Blood downgraded to Sector Perform from Outperform at RBC Capital
08/08/22 Cowen
Global Blood Therapeutics downgraded to Market Perform from Outperform at Cowen
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/09/22 Mizuho
Nvidia price target lowered to $250 from $290 at Mizuho
08/08/22 Summit Insights
Nvidia underestimated its exposure to crypto mining, says Summit Insights
08/08/22 Oppenheimer
Nvidia price target lowered to $250 from $300 at Oppenheimer
08/08/22 Truist
Nvidia price target lowered to $216 from $283 at Truist
CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

07/29/22 Evercore ISI
Carlyle Group upgraded to Outperform from In Line at Evercore ISI
07/13/22 Deutsche Bank
Carlyle Group price target lowered to $56 from $64 at Deutsche Bank
06/08/22 JMP Securities
Carlyle Group initiated with an Outperform at JMP Securities
05/19/22 Deutsche Bank
Carlyle Group price target lowered to $64 from $68 at Deutsche Bank
TSLA Tesla
$870.99 /

+6.51 (+0.75%)

08/08/22 Canaccord
Tesla price target raised to $881 from $815 at Canaccord
08/03/22 Morgan Stanley
Tesla exposed to both risk and opportunity of battery race, says Morgan Stanley
08/02/22 Citi
Tesla price target raised to $424 from $375 at Citi
EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

07/18/22 Mizuho
Emerson Electric price target lowered to $85 from $100 at Mizuho
07/13/22 Deutsche Bank
Emerson Electric price target lowered to $97 from $110 at Deutsche Bank
07/12/22 Wells Fargo
Emerson Electric price target raised to $89 from $87 at Wells Fargo
07/08/22 Barclays
Emerson Electric price target lowered to $80 from $87 at Barclays
FSLR First Solar
$106.66 /

+4.78 (+4.69%)

08/08/22 JPMorgan
First Solar upgraded to Overweight from Neutral at JPMorgan
08/08/22 Guggenheim
First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act
08/08/22 Guggenheim
First Solar upgraded to Buy from Neutral at Guggenheim
08/05/22 Argus
First Solar price target raised to $123 from $104 at Argus
TPIC TPI Composites
$21.41 /

+2.64 (+14.06%)

08/08/22 JPMorgan
TPI Composites upgraded to Overweight from Neutral at JPMorgan
08/04/22 Cowen
TPI Composites price target raised to $20 from $15 at Cowen
07/19/22 Piper Sandler
TPI Composites price target lowered to $12 from $14 at Piper Sandler
05/06/22 Roth Capital
TPI Composites upgraded to Buy from Neutral at Roth Capital
ROKU Roku
$83.56 /

+1.32 (+1.61%)

08/08/22 Pivotal Research
Roku downgraded to Sell from Hold at Pivotal Research
08/03/22 Citi
Roku price target lowered to $125 from $165 at Citi
08/01/22 Morgan Stanley
Roku price target lowered to $55 from $80 at Morgan Stanley
07/29/22 BofA
BofA double downgrades Roku with headwinds seen lasting 2-3 quarters
WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

08/08/22 Barrington
Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
08/05/22 Wells Fargo
Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
08/05/22 Barclays
Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
08/04/22 Credit Suisse
Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
WDC Western Digital
$47.53 /

+0.42 (+0.89%)

08/08/22 Craig-Hallum
Western Digital price target lowered to $85 from $90 at Craig-Hallum
08/08/22 Deutsche Bank
Western Digital price target lowered to $56 from $64 at Deutsche Bank
08/08/22 Benchmark
Western Digital downgraded to Hold at Benchmark amid sharp inventory correction
08/08/22 Baird
Western Digital price target lowered to $55 from $75 at Baird
CVS CVS Health
$102.00 /

-0.34 (-0.33%)

08/09/22 Deutsche Bank
Signify Health, CVS deal could be 'win-win,' says Deutsche Bank
08/08/22 BofA
CVS deal for Signify would help with continued evolution, says BofA
08/04/22 Evercore ISI
CVS Health removed from 'TAP Outperform' list at Evercore ISI
08/04/22 Deutsche Bank
CVS Health price target raised to $120 from $113 at Deutsche Bank
GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

08/03/22 Tigress Financial
Alphabet price target raised to $186 from $183 at Tigress Financial
07/27/22 Truist
Chrome cookie phase-out delay positive for Criteo, says Truist
07/27/22 KeyBanc
Google's cookie phase-out delay not surprising, says KeyBanc
07/27/22 RBC Capital
Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

SONO Sonos
$22.98 /

-0.215 (-0.93%)

06/14/22 Morgan Stanley
Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
06/14/22 Morgan Stanley
Sonos downgraded to Equal Weight from Overweight at Morgan Stanley
05/31/22 Jefferies
Sonos price target lowered to $35 from $45 at Jefferies
05/12/22 DA Davidson
Sonos price target lowered to $40 from $49 at DA Davidson
SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

08/08/22 Cowen
Signify Health price target raised to $24 from $14 at Cowen
08/04/22 Piper Sandler
Signify Health price target raised to $34 from $32 at Piper Sandler
BA Boeing
$165.90 /

+0.89 (+0.54%)

08/01/22 Morgan Stanley
Morgan Stanley says Boeing approval to resume 787 deliveries a positive catalyst
08/01/22 Goldman Sachs
Boeing 787 resumption would clear 'significant overhang,' says Goldman Sachs
08/01/22 Citi
Boeing news removes $33 per share of downside risk, says Citi
07/28/22 JPMorgan
Boeing price target raised to $200 from $188 at JPMorgan
AMZN Amazon.com
$139.42 /

-1.37 (-0.97%)

08/08/22 B. Riley
B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
08/05/22 DA Davidson
Amazon may be be more willing to do M&A under Jassy, says DA Davidson
07/29/22 UBS
Amazon.com price target raised to $180 from $167 at UBS
07/29/22 BofA
Amazon price target bumped to $170 at BofA after 'mostly positive' quarter
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

08/09/22 Mizuho
Karuna Therapeutics price target raised to $276 from $190 at Mizuho
08/09/22 Citi
Zai Lab price target raised to $199 from $193 at Citi
08/09/22 BofA
Karuna Therapeutics price target raised to $261 from $160 at BofA
08/08/22 Stifel
Cerevel Therapeutics price target raised to $54 from $50 at Stifel
CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

08/08/22 Oppenheimer
CinCor Pharma price target raised to $60 from $35 at Oppenheimer
07/21/22 Oppenheimer
CinCor Pharma price target raised to $35 from $30 at Oppenheimer
02/01/22 Oppenheimer
CinCor Pharma initiated with an Outperform at Oppenheimer
02/01/22 Evercore ISI
CinCor Pharma initiated with an Outperform at Evercore ISI
WTI W&T Offshore
$5.37 /

+0.775 (+16.87%)

07/27/22 Stifel
Stifel keeps Buy on W&T Offshore, raises price target to $8.40
10/20/21 Stifel
W&T Offshore upgraded to Buy at Stifel on improving prices
10/20/21 Stifel
W&T Offshore upgraded to Buy from Hold at Stifel
09/09/21 Roth Capital
W&T Offshore should be bought on any weakness, says Roth Capital
QURE uniQure
$18.60 /

-6.92 (-27.12%)

08/09/22 Wells Fargo
uniQure price target lowered to $24 from $34 at Wells Fargo
08/09/22 H.C. Wainwright
uniQure selloff brings attractive entry point, says H.C. Wainwright
08/08/22 Chardan
uniQure price target lowered to $60 from $65 at Chardan
08/08/22 Truist
uniQure's high-dose HD data still on track for 1H23, says Truist
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/09/22 Baird
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird
08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
PLTR Palantir
$9.82 /

-1.625 (-14.20%)

08/09/22 Morgan Stanley
Palantir price target lowered to $11 from $13 at Morgan Stanley
08/09/22 Citi
Palantir price target lowered to $6 from $7 at Citi
08/09/22 Deutsche Bank
Palantir downgraded to Sell from Hold at Deutsche Bank
08/08/22 Jefferies
Palantir price target lowered to $12 from $13 at Jefferies
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

08/09/22 Stephens
Tyson Foods price target lowered to $95 from $100 at Stephens
08/09/22 BMO Capital
Tyson Foods price target lowered to $90 from $99 at BMO Capital
08/09/22 Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
08/09/22 Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
BNTX BioNTech
$169.30 /

-13.9 (-7.59%)

07/13/22 SVB Securities
BioNTech upgraded to Outperform from Market Perform at SVB Securities
07/11/22 H.C. Wainwright
BioNTech price target lowered to $283 from $298 at H.C. Wainwright
07/06/22 Canaccord
BioNTech assumed with a Buy at Canaccord
06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
ELAN Elanco
$19.94 /

+0.47 (+2.41%)

07/21/22 Goldman Sachs
Elanco downgraded to Sell from Buy at Goldman Sachs
07/18/22 Cowen
Cowen believes Global Pharma quarterly results will be strong
07/18/22 JPMorgan
JPMorgan cuts Elanco target, Zoetis remains top animal health idea
07/11/22 Piper Sandler
Elanco initiated with a Neutral at Piper Sandler
SRCL Stericycle
$52.40 /

+1.85 (+3.66%)

08/08/22 RBC Capital
Stericycle price target lowered to $70 from $82 at RBC Capital
05/12/22 Berenberg
Stericycle downgraded on inflationary environment at Berenberg
05/12/22 Berenberg
Stericycle downgraded to Hold from Buy at Berenberg
04/29/22 Baird
Stericycle price target lowered to $63 from $72 at Baird
WTI W&T Offshore
$5.37 /

+0.775 (+16.87%)

WDC Western Digital
$47.53 /

+0.42 (+0.89%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

TWTR Twitter
$42.93 /

+0.4 (+0.94%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSLA Tesla
$870.99 /

+6.51 (+0.75%)

TPIC TPI Composites
$21.41 /

+2.64 (+14.06%)

SRCL Stericycle
$52.40 /

+1.85 (+3.66%)

SONO Sonos
$22.98 /

-0.215 (-0.93%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

ROKU Roku
$83.56 /

+1.32 (+1.61%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

ELAN Elanco
$19.94 /

+0.47 (+2.41%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

BNTX BioNTech
$169.30 /

-13.9 (-7.59%)

BA Boeing
$165.90 /

+0.89 (+0.54%)

AMZN Amazon.com
$139.42 /

-1.37 (-0.97%)

  • 10
    Aug
  • 07
    Jan
  • 10
    Nov
  • 10
    Nov
WDC Western Digital
$47.53 /

+0.42 (+0.89%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

TWTR Twitter
$42.93 /

+0.4 (+0.94%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSLA Tesla
$870.99 /

+6.51 (+0.75%)

SONO Sonos
$22.98 /

-0.215 (-0.93%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

ROKU Roku
$83.56 /

+1.32 (+1.61%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

BNTX BioNTech
$169.30 /

-13.9 (-7.59%)

BA Boeing
$165.90 /

+0.89 (+0.54%)

AMZN Amazon.com
$139.42 /

-1.37 (-0.97%)

WTI W&T Offshore
$5.37 /

+0.775 (+16.87%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

TWTR Twitter
$42.93 /

+0.4 (+0.94%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSLA Tesla
$870.99 /

+6.51 (+0.75%)

TPIC TPI Composites
$21.41 /

+2.64 (+14.06%)

SONO Sonos
$22.98 /

-0.215 (-0.93%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

ROKU Roku
$83.56 /

+1.32 (+1.61%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

ELAN Elanco
$19.94 /

+0.47 (+2.41%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

BNTX BioNTech
$169.30 /

-13.9 (-7.59%)

BA Boeing
$165.90 /

+0.89 (+0.54%)

AMZN Amazon.com
$139.42 /

-1.37 (-0.97%)

WTI W&T Offshore
$5.37 /

+0.775 (+16.87%)

WDC Western Digital
$47.53 /

+0.42 (+0.89%)

WBD Warner Bros. Discovery
$14.01 /

-0.58 (-3.98%)

TWTR Twitter
$42.93 /

+0.4 (+0.94%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSLA Tesla
$870.99 /

+6.51 (+0.75%)

SONO Sonos
$22.98 /

-0.215 (-0.93%)

ROKU Roku
$83.56 /

+1.32 (+1.61%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

GOOGL Alphabet
$117.32 /

-0.17 (-0.14%)

GOOG Alphabet
$118.17 /

-0.11 (-0.09%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CINC CinCor Pharma
$34.96 /

+11.46 (+48.77%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

BNTX BioNTech
$169.30 /

-13.9 (-7.59%)

BA Boeing
$165.90 /

+0.89 (+0.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.